Acquisition of Ascyrus (Details) $ in Thousands		1 Months Ended	3 Months Ended		6 Months Ended
	Sep. 02, 2020 USD ($)	Jul. 31, 2026 USD ($)	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)	Dec. 31, 2025 USD ($)
Business Combination [Line Items]
Current portion of contingent consideration			$ 25,000		$ 25,000		$ 20,690
Change in fair value of contingent consideration					9,710	$ (210)
Ascyrus Medical LLC
Business Combination [Line Items]
Equity ownership percent	100.00%
Cash consideration	$ 60,000
Common stock value issued in business combination	20,000
Business combination, contingent consideration, liability			70,300		70,300		$ 60,600
Current portion of contingent consideration			25,000		25,000
Change in fair value of contingent consideration			$ 8,000	$ 2,600	$ 9,700	$ (200)
Ascyrus Medical LLC | Subsequent Event
Business Combination [Line Items]
Payment for contingent consideration liability, financing activities		$ 25,000
Ascyrus Medical LLC | Measurement Input, Discount Rate
Business Combination [Line Items]
Contingent consideration, measurement input			0.16		0.16
Ascyrus Medical LLC | FDA Approval IDE for AMDS
Business Combination [Line Items]
Cash consideration	10,000
Common stock value issued in business combination	10,000
Ascyrus Medical LLC | FDA Approval PMA for AMDS
Business Combination [Line Items]
Cash consideration	25,000
Ascyrus Medical LLC | AMDS Obtained In Japan
Business Combination [Line Items]
Cash consideration	10,000
Ascyrus Medical LLC | AMDS Obtained In China
Business Combination [Line Items]
Cash consideration	10,000
Ascyrus Medical LLC | Additional Potential Cash Payment If Japan Or China Obtains Approval
Business Combination [Line Items]
Cash consideration	$ 55,000
Ascyrus Medical LLC | Following FDA Approval For AMDS
Business Combination [Line Items]
Aggregate amount of consideration transferred					$ 100,000
Period of required contingent consideration	3 years
Ascyrus Medical LLC | Maximum
Business Combination [Line Items]
Aggregate amount of consideration transferred	$ 200,000
Ascyrus Medical LLC | Maximum | Additional Potential Cash Payment If Japan Or China Obtains Approval
Business Combination [Line Items]
Cash consideration	75,000
Ascyrus Medical LLC | Minimum | Additional Potential Cash Payment If Japan Or China Obtains Approval
Business Combination [Line Items]
Cash consideration	$ 65,000